ArticleEpilepsy & behavior reports2025

Long-term efficacy and safety of perampanel in patients aged 60 years and older with focal seizures: Post hoc analysis of phase III open-label extension studies stratified by enzyme-inducing anti-seizure medication use.

Rohit Marawar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.